Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Fukai and Associates
mi
from
Louisville, CO
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Fukai and Associates
mi
from
Louisville, CO
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Peter C. Donshik, MD, PC
mi
from
Bloomfield, CT
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Peter C. Donshik, MD, PC
mi
from
Bloomfield, CT
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Dr. Ted Brink and Associates
mi
from
Jacksonville, FL
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Dr. Ted Brink and Associates
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Jack J. Yager, OD
mi
from
Orlando, FL
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Jack J. Yager, OD
mi
from
Orlando, FL
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Clayton Eye Center
mi
from
Morrow, GA
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Clayton Eye Center
mi
from
Morrow, GA
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Eyecare Associates
mi
from
Bloomington, IL
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Eyecare Associates
mi
from
Bloomington, IL
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Drs. Hawks, Besler & Rogers
mi
from
Gardner, KA
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Drs. Hawks, Besler & Rogers
mi
from
Gardner, KA
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Lee Rigel
mi
from
East Lansing, MI
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Lee Rigel
mi
from
East Lansing, MI
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Univ Missouri at St. Louis, College of Optometry
mi
from
St. Louis, MO
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Univ Missouri at St. Louis, College of Optometry
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
InSight Eyecare
mi
from
Warrensburg, MO
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
InSight Eyecare
mi
from
Warrensburg, MO
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Drs. Quinn, Quinn and Associates
mi
from
Athens, OH
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Drs. Quinn, Quinn and Associates
mi
from
Athens, OH
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Central Ohio Eyecare
mi
from
Columbus, OH
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Central Ohio Eyecare
mi
from
Columbus, OH
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Kenji Hamada, OD
mi
from
Grants Pass, OR
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Kenji Hamada, OD
mi
from
Grants Pass, OR
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
West Hills Vision Center
mi
from
Moon Township, PA
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
West Hills Vision Center
mi
from
Moon Township, PA
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Kenneth A. Young, OD
mi
from
Brentwood, TN
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Kenneth A. Young, OD
mi
from
Brentwood, TN
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Gary W. Jerkins, MD
mi
from
Nashville, TN
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Gary W. Jerkins, MD
mi
from
Nashville, TN
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Premier Vision
mi
from
Amarillo, TX
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Premier Vision
mi
from
Amarillo, TX
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Charles Wegman, OD
mi
from
Carrollton, TX
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Charles Wegman, OD
mi
from
Carrollton, TX
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Wishnow-Sugar Vision Group
mi
from
Katy, TX
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Wishnow-Sugar Vision Group
mi
from
Katy, TX
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
First Eye Care Plano
mi
from
Plano, TX
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
First Eye Care Plano
mi
from
Plano, TX
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Dr. William Bogus
mi
from
Salt Lake City, UT
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Dr. William Bogus
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Scott Jens, OD
mi
from
Middleton, WI
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Scott Jens, OD
mi
from
Middleton, WI
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Snowy Range Vision Center
mi
from
Laramie, WY
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Snowy Range Vision Center
mi
from
Laramie, WY
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated:  2/26/2016
UAB School of Optometry
mi
from
Birmingham, AL
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated: 2/26/2016
UAB School of Optometry
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated:  2/26/2016
Sall Research Medical Center, Inc.
mi
from
Artesia, CA
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated: 2/26/2016
Sall Research Medical Center, Inc.
mi
from
Artesia, CA
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated:  2/26/2016
North Valley Eye Medical Group, Inc.
mi
from
Mission Hills, CA
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated: 2/26/2016
North Valley Eye Medical Group, Inc.
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated:  2/26/2016
Wolstan & Goldberg Eye Associates
mi
from
Torrance, CA
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated: 2/26/2016
Wolstan & Goldberg Eye Associates
mi
from
Torrance, CA
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated:  2/26/2016
Tauber Eye Center
mi
from
Kansas City, MO
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated: 2/26/2016
Tauber Eye Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated:  2/26/2016
South Shore Eye Center, LLP
mi
from
Wantagh, NY
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated: 2/26/2016
South Shore Eye Center, LLP
mi
from
Wantagh, NY
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated:  2/26/2016
Abrams Eye Center
mi
from
Cleveland, OH
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated: 2/26/2016
Abrams Eye Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated:  2/26/2016
Virginia Eye Consultants
mi
from
Norfolk, VA
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated: 2/26/2016
Virginia Eye Consultants
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury
Safety and Efficacy of the BrainPort V200 Device in Individuals Blinded by Traumatic Injury
Status: Enrolling
Updated:  3/1/2016
The Chicago Lighthouse for People Who Are Blind or Visually Impaired
mi
from
Chicago, IL
A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury
Safety and Efficacy of the BrainPort V200 Device in Individuals Blinded by Traumatic Injury
Status: Enrolling
Updated: 3/1/2016
The Chicago Lighthouse for People Who Are Blind or Visually Impaired
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury
Safety and Efficacy of the BrainPort V200 Device in Individuals Blinded by Traumatic Injury
Status: Enrolling
Updated:  3/1/2016
Lighthouse Guild
mi
from
New York, NY
A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury
Safety and Efficacy of the BrainPort V200 Device in Individuals Blinded by Traumatic Injury
Status: Enrolling
Updated: 3/1/2016
Lighthouse Guild
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury
Safety and Efficacy of the BrainPort V200 Device in Individuals Blinded by Traumatic Injury
Status: Enrolling
Updated:  3/1/2016
Wicab, Inc.
mi
from
Middleton, WI
A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury
Safety and Efficacy of the BrainPort V200 Device in Individuals Blinded by Traumatic Injury
Status: Enrolling
Updated: 3/1/2016
Wicab, Inc.
mi
from
Middleton, WI
Click here to add this to my saved trials
A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens Patients
A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens Patients
Status: Enrolling
Updated:  3/1/2016
Hazleton Eye Specialists
mi
from
Hazleton, PA
A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens Patients
A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens Patients
Status: Enrolling
Updated: 3/1/2016
Hazleton Eye Specialists
mi
from
Hazleton, PA
Click here to add this to my saved trials
A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib
A 24-month Randomized, Double-masked, Sham Controlled, Multicenter, Phase IIIB Study Comparing Photodynamic Therapy With Verteporfin (Visudyne®) Plus Two Different Dose Regimens of Intravitreal Triamcinolone Acetonide (1 mg and 4 mg) Versus Visudyne® Plus Intravitreal Pegaptanib(Macugen®) in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  3/3/2016
Novartis Investigational Site
mi
from
Austin, TX
A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib
A 24-month Randomized, Double-masked, Sham Controlled, Multicenter, Phase IIIB Study Comparing Photodynamic Therapy With Verteporfin (Visudyne®) Plus Two Different Dose Regimens of Intravitreal Triamcinolone Acetonide (1 mg and 4 mg) Versus Visudyne® Plus Intravitreal Pegaptanib(Macugen®) in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 3/3/2016
Novartis Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated:  3/7/2016
Clinical Research Facility
mi
from
Worcester, MA
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated: 3/7/2016
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated:  3/7/2016
Clinical Research Facility
mi
from
Omaha, NE
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated: 3/7/2016
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated:  3/7/2016
Clinical Research Facility
mi
from
Slingerlands, NY
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated: 3/7/2016
Clinical Research Facility
mi
from
Slingerlands, NY
Click here to add this to my saved trials
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated:  3/7/2016
Clinical Research Facility
mi
from
Cleveland, OH
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated: 3/7/2016
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated:  3/7/2016
Clinical Research Facility
mi
from
Arlington, TX
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated: 3/7/2016
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated:  3/7/2016
Investigator Site 102
mi
from
Brno,
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated: 3/7/2016
Investigator Site 102
mi
from
Brno,
Click here to add this to my saved trials
A Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  3/7/2016
Clinical Research Facility
mi
from
Phoenix, AZ
A Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 3/7/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy
The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy
Status: Enrolling
Updated:  3/7/2016
Hunter Health Clinic
mi
from
Wichita, KA
The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy
The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy
Status: Enrolling
Updated: 3/7/2016
Hunter Health Clinic
mi
from
Wichita, KA
Click here to add this to my saved trials
The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy
The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy
Status: Enrolling
Updated:  3/7/2016
Yellowhawk Tribal Health Center
mi
from
Pendleton, OR
The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy
The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy
Status: Enrolling
Updated: 3/7/2016
Yellowhawk Tribal Health Center
mi
from
Pendleton, OR
Click here to add this to my saved trials
Determinants of Compliance With Glaucoma Therapy
Determinants of Compliance With Glaucoma Therapy
Status: Enrolling
Updated:  3/7/2016
Devers Eye Institute
mi
from
Portland, OR
Determinants of Compliance With Glaucoma Therapy
Determinants of Compliance With Glaucoma Therapy
Status: Enrolling
Updated: 3/7/2016
Devers Eye Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Dextromethorphan for Diabetic Macular Edema
A Pilot Phase I/II Study for the Evaluation of Dextromethorphan as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema (MiDME2)
Status: Enrolling
Updated:  3/9/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Dextromethorphan for Diabetic Macular Edema
A Pilot Phase I/II Study for the Evaluation of Dextromethorphan as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema (MiDME2)
Status: Enrolling
Updated: 3/9/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure
The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure
Status: Enrolling
Updated:  3/10/2016
University of Colorado Eye Center
mi
from
Aurora, CO
The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure
The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure
Status: Enrolling
Updated: 3/10/2016
University of Colorado Eye Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
CANOPY: Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
Status: Enrolling
Updated:  3/14/2016
Abbott Vascular
mi
from
Santa Clara, CA
Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
CANOPY: Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
Status: Enrolling
Updated: 3/14/2016
Abbott Vascular
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Validation of TearLab Osmometer - Human Factor Usability Report
Validation of TearLab Osmometer - Human Factor Usability Report
Status: Enrolling
Updated:  3/14/2016
Gordon Binder Weiss Vision Institute
mi
from
San Diego, CA
Validation of TearLab Osmometer - Human Factor Usability Report
Validation of TearLab Osmometer - Human Factor Usability Report
Status: Enrolling
Updated: 3/14/2016
Gordon Binder Weiss Vision Institute
mi
from
San Diego, CA
Click here to add this to my saved trials